• Home
  • About
    • Our Constitution
    • Chairman’s words
    • Chairman and Board Members
  • Members
    • Become a Member
  • Annual Meetings
    • 1st Annual Meeting – 2010
    • 2nd Annual Meeting – 2011
    • 3rd Annual Meeting – 2012
    • 4th Annual Meeting -2013
    • 5th Annual Meeting- 2014
    • 7th Annual Meeting -2016
    • 8th Annual Meeting -2017
    • 9th Annual Meeting -2018
    • 10th Annual Meeting
    • 11th Annual Meeting
    • 12th Annual Meeting
  • Abstracts
    • Abstracts 2010
    • Abstracts 2011
    • Abstracts 2012
    • Abstracts 2014
    • Abstracts 2015
    • Abstracts 2016
    • Abstracts 2017
    • Abstracts 2018
    • Full Abstract List
  • Organizations
    • ISMFM
    • Israel Medical Association
    • Placenta – The Official Jourmal of IFPA
    • The Israel Fertility Association
    • SMFM
    • International Federation of Placenta Associations
    • The Endocrine Society of Australia
    • Nano Science
    • The Society for Reproductive Biology
    • Australasian Diabetes in Pregnancy Society
    • Society of Theriogenology
    • American College of Theriogenologists
    • The Fetal Medicine Foundation
  • Contact
Menu
  • Home
  • About
    • Our Constitution
    • Chairman’s words
    • Chairman and Board Members
  • Members
    • Become a Member
  • Annual Meetings
    • 1st Annual Meeting – 2010
    • 2nd Annual Meeting – 2011
    • 3rd Annual Meeting – 2012
    • 4th Annual Meeting -2013
    • 5th Annual Meeting- 2014
    • 7th Annual Meeting -2016
    • 8th Annual Meeting -2017
    • 9th Annual Meeting -2018
    • 10th Annual Meeting
    • 11th Annual Meeting
    • 12th Annual Meeting
  • Abstracts
    • Abstracts 2010
    • Abstracts 2011
    • Abstracts 2012
    • Abstracts 2014
    • Abstracts 2015
    • Abstracts 2016
    • Abstracts 2017
    • Abstracts 2018
    • Full Abstract List
  • Organizations
    • ISMFM
    • Israel Medical Association
    • Placenta – The Official Jourmal of IFPA
    • The Israel Fertility Association
    • SMFM
    • International Federation of Placenta Associations
    • The Endocrine Society of Australia
    • Nano Science
    • The Society for Reproductive Biology
    • Australasian Diabetes in Pregnancy Society
    • Society of Theriogenology
    • American College of Theriogenologists
    • The Fetal Medicine Foundation
  • Contact
Facebook
Telomere Homeostasis In Trophoblasts From Pregnancies Complicated With Preeclampsia As Well As In Cord Blood
Home ‹ 2014 Abstracts ‹ Telomere Homeostasis In Trophoblasts From Pregnancies Complicated With Preeclampsia As Well As In Cord Blood

Rivka Sukenik-Halevy,a,b,c Aliza Amiel b,d , Dvora  Kidron c,e, Meital Libermanb ,

Yael Ganor-Paz a,c ,Tal Biron-Shental a,c

a Department of OBGYN, Meir Medical Center, Kfar Saba, Israel. b Genetic Institute, Meir Medical Center, Kfar Saba, Israel. c  Sackler School of Medicine, Tel Aviv University, Tel Aviv, Kfar Saba, Israel. d  Faculty of Life Science, Bar-Ilan University, Ramat Gan, Kfar Saba, Israel. e Department of Pathology, Meir Medical Center, Kfar Saba, Israel

Objective: Telomere shortening and elevated aggregate formation have been observed in throphoblasts from pregnancies complicated with Preeclampsia. In this study we opted to look into the mechanisms of telomere shortening in these cases as well as to assess telomere length and homeostasis in fetal cord blood.

Study Design: Placental specimens and cord blood from pregnancies complicated with preeclampsia and from uncomplicated pregnancies were collected. In throphoblases as well as in cord blood, the percentage of cells with fragmented nuclei: senescence-associated heterochromatin foci (SAHF), was calculated using DAPI staining. Florescence in situ hybridization (FISH) was used to assess the TERC gene copy number as well as the Telomere capture phenomenon (TC). Telomere length and aggregate formation was assessed in cord blood using quantitative FISH.

Results:  In trophoblasts, the percentage of cells with SAHF was higher in PET compared to control samples, (56.8 ± 10.5% vs. 35.2± 10.7%, P = 0.028). The percentage of cells with abnormal TERC copy number was also increased in PET compared to controls, (28.48 ± 9.3% vs. 12.9± 15%, P = 0.006) as well as the percentage of cells with Telomere capture (27.4 ± 9.4% vs. 16± 4.67%, P = 0.028). In cord blood, no differences were observed in telomere length, aggregate formation, TERC copy number, TC or SAHF between PET and controls.

Conclusions: We suggest that telomere shortening in PET trophoblasts is linked to cellular increased senescence.  Alterations in telomere homeostasis mechanisms are present in such cases. These findings support the role of telomeres in the pathogenesis of trophoblastic dysfunction in preeclampsia. The lack of telomere shortening, modified telomere homeostasis mechanisms and increased senescence in cord blood suggests that these processes are probably mainly located to the placenta.

 

« Previous
Next »
Powered by Netmii and Art + Web
All rights reserved to ISPR -Israel Society for Placental Research
Scroll to top